STKH
STKH
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $-1.722M | $-1.922M | 0% | $-1.75 | $-1.585M |
| Q1-2025 | $0 ▼ | $-1.722M ▼ | $-1.922M ▲ | 0% ▲ | $-1.75 ▲ | $-1.585M ▲ |
| Q4-2024 | $5K | $2.051M | $-2.093M | -41.86K% | $-24 | $-1.93M |
| Q3-2024 | $5K ▲ | $2.051M ▼ | $-2.093M ▲ | -41.86K% ▼ | $-24 ▲ | $-1.93M ▲ |
| Q2-2024 | $0 | $2.181M | $-2.167M | 0% | $-27 | $-2.074M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $1.425M | $5.858M | $1.747M | $4.111M ▲ |
| Q1-2025 | $1.425M ▲ | $5.858M ▼ | $1.747M ▼ | $4.111M ▲ |
| Q4-2024 | $1.362M | $7.787M | $3.74M | $4.047M |
| Q3-2024 | $1.362M ▼ | $7.787M ▼ | $3.74M ▼ | $4.047M ▼ |
| Q2-2024 | $5.668M | $12.154M | $4.389M | $7.765M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-1.922M | $-1.407M | $-729K | $2.182M | $0 | $-1.444M |
| Q1-2025 | $-1.922M ▲ | $-1.407M ▲ | $-729K ▼ | $2.182M ▲ | $0 | $-1.444M ▲ |
| Q4-2024 | $-2.093M | $-2.041M | $-290K | $199.5K | $0 ▲ | $-2.361M |
| Q3-2024 | $-2.093M ▼ | $-2.041M ▼ | $-290K ▼ | $199.5K ▲ | $-5.436M ▼ | $-2.361M ▼ |
| Q2-2024 | $-2.167K | $-2.188K | $-187.5 | $2.993K | $594 | $-2.36K |
Five-Year Company Overview
Income Statement
Balance Sheet
Cash Flow
Competitive Edge
Innovation and R&D
Summary
Steakholder Foods is an early‑stage, high‑risk food‑tech platform company: strong on innovation, very weak so far on commercial proof and financial self‑sufficiency. The financials show a typical pre‑revenue, loss‑making profile backed by a small asset base, no debt, and ongoing cash burn, implying dependence on capital markets and potential further dilution. Strategically, the firm is pursuing a differentiated B2B role as a technology and ingredient provider to the wider alternative protein industry, supported by advanced 3D bioprinting capabilities and a growing IP portfolio. The major opportunity lies in enabling realistic, structured alternative meat and fish at scale, and eventually cultivated meat, while the major risks relate to funding needs, competitive intensity, regulatory and consumer acceptance, and the challenge of turning scientific progress into sustainable, repeatable revenue. Observers will want to track concrete adoption by manufacturers, growth in recurring orders, and the company’s ability to manage its cash runway as the main indicators of whether its vision can translate into a viable business.
About Steakholder Foods Ltd.
https://www.meatech3d.comMeaTech 3D Ltd., a deep-tech food company, engages in the development of cultivated meat technologies to manufacture cultivated meat without animal slaughter. The company develops a three-dimensional bioprinter to deposit layers of differentiated stem cells, scaffolding, and cell nutrients in a three-dimensional form of structured cultured meat.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $0 | $-1.722M | $-1.922M | 0% | $-1.75 | $-1.585M |
| Q1-2025 | $0 ▼ | $-1.722M ▼ | $-1.922M ▲ | 0% ▲ | $-1.75 ▲ | $-1.585M ▲ |
| Q4-2024 | $5K | $2.051M | $-2.093M | -41.86K% | $-24 | $-1.93M |
| Q3-2024 | $5K ▲ | $2.051M ▼ | $-2.093M ▲ | -41.86K% ▼ | $-24 ▲ | $-1.93M ▲ |
| Q2-2024 | $0 | $2.181M | $-2.167M | 0% | $-27 | $-2.074M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $1.425M | $5.858M | $1.747M | $4.111M ▲ |
| Q1-2025 | $1.425M ▲ | $5.858M ▼ | $1.747M ▼ | $4.111M ▲ |
| Q4-2024 | $1.362M | $7.787M | $3.74M | $4.047M |
| Q3-2024 | $1.362M ▼ | $7.787M ▼ | $3.74M ▼ | $4.047M ▼ |
| Q2-2024 | $5.668M | $12.154M | $4.389M | $7.765M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q2-2025 | $-1.922M | $-1.407M | $-729K | $2.182M | $0 | $-1.444M |
| Q1-2025 | $-1.922M ▲ | $-1.407M ▲ | $-729K ▼ | $2.182M ▲ | $0 | $-1.444M ▲ |
| Q4-2024 | $-2.093M | $-2.041M | $-290K | $199.5K | $0 ▲ | $-2.361M |
| Q3-2024 | $-2.093M ▼ | $-2.041M ▼ | $-290K ▼ | $199.5K ▲ | $-5.436M ▼ | $-2.361M ▼ |
| Q2-2024 | $-2.167K | $-2.188K | $-187.5 | $2.993K | $594 | $-2.36K |
Five-Year Company Overview
Income Statement
Balance Sheet
Cash Flow
Competitive Edge
Innovation and R&D
Summary
Steakholder Foods is an early‑stage, high‑risk food‑tech platform company: strong on innovation, very weak so far on commercial proof and financial self‑sufficiency. The financials show a typical pre‑revenue, loss‑making profile backed by a small asset base, no debt, and ongoing cash burn, implying dependence on capital markets and potential further dilution. Strategically, the firm is pursuing a differentiated B2B role as a technology and ingredient provider to the wider alternative protein industry, supported by advanced 3D bioprinting capabilities and a growing IP portfolio. The major opportunity lies in enabling realistic, structured alternative meat and fish at scale, and eventually cultivated meat, while the major risks relate to funding needs, competitive intensity, regulatory and consumer acceptance, and the challenge of turning scientific progress into sustainable, repeatable revenue. Observers will want to track concrete adoption by manufacturers, growth in recurring orders, and the company’s ability to manage its cash runway as the main indicators of whether its vision can translate into a viable business.
CEO
Arik Kaufman
Compensation Summary
(Year 2024)
CEO
Arik Kaufman
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-09-10 | Reverse | 1:8 |
| 2025-04-28 | Reverse | 1:5 |
| 2024-04-04 | Reverse | 1:10 |
Ratings Snapshot
Rating : C-